HALEON PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
21 July 2022
Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them.
On 21 July 2022, Haleon plc (the "Company") received notification of the following transactions as detailed below .
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Tobias Hestler |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Chief Financial Officer - Person Discharging Managerial Responsibilities |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Haleon plc |
|||
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). |
|||
|
|
||||
Identification code |
GB00BMX86B70 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
n/a |
1,033 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
1,033 |
||||
|
|
||||
- Price |
n/a |
||||
|
|
||||
e)
|
Date of the transaction
|
18 July 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Amy Landucci |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Haleon plc |
|||
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). |
|||
|
|
||||
Identification code |
GB00BMX86B70 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
n/a |
379 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
379 |
||||
|
|
||||
- Price |
n/a |
||||
|
|
||||
e)
|
Date of the transaction
|
18 July 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Bart Derde |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Chief Supply Chain Officer - Person Discharging Managerial Responsibilities |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Haleon plc |
|||
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction - please refer to the Prospectus for more information on the capital reduction). |
|||
|
|
||||
Identification code |
GB00BMX86B70 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
n/a |
837 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
837 |
||||
|
|
||||
- Price |
n/a |
||||
|
|
||||
e)
|
Date of the transaction
|
18 July 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Jooyong Lee |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Head of Strategy and Office of the CEO - Person Discharging Managerial Responsibilities |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Haleon plc |
|||
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). |
|||
|
|
||||
Identification code |
GB00BMX86B70 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
n/a |
386 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
386 |
||||
|
|
||||
- Price |
n/a |
||||
|
|
||||
e)
|
Date of the transaction
|
18 July 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Tamara Rogers |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Chief Marketing Officer - Person Discharging Managerial Responsibilities |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||
a)
|
Name
|
Haleon plc |
|||
b)
|
LEI
|
549300PSB3WWEODCUP19 |
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||
a)
|
Description of the financial instrument, type of instrument |
Haleon plc Ordinary shares of £1.25 each (to be reduced to 1 pence following Haleon plc's capital reduction -please refer to the Prospectus for more information on the capital reduction). |
|||
|
|
||||
Identification code |
GB00BMX86B70 |
||||
|
|
||||
b)
|
Nature of the transaction
|
Ordinary shares in the Company received on 18 July 2022 in respect of shares held in the GSK Share Reward Plan and in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
|
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
n/a |
937 |
|
|
|
|
|
|
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
937 |
||||
|
|
||||
- Price |
n/a |
||||
|
|
||||
e)
|
Date of the transaction
|
18 July 2022 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
Amanda Mellor
Company Secretary